My recent email exchange with Doug with the most recent email, to which he hasn’t responded, at the top:
Hi Doug,
Peter stated that BioPath anticipated the study to start by September 8th. There was never an official announcement or press release regarding the opening of enrollment of the phase 2 portion for CML. In addition, the website still indicates that the CML study is preparing for enrollment and clinicaltrials.gov has the status as “this study is not yet open for participant enrollment”
Which is it? Is the study open? Is the PI and their team actively recruiting eligible patients for this study at this point? If this is the case, why not issue a formal press release? Why are news and updates from the company so hard get?
Regards,
Brett
Sent from my iPhone
On Oct 9, 2017, at 12:25 PM, Doug Morris <dmorris@biopathholdings.com> wrote:
I believe It was stated in Peter's last presentation on September 5th at the Rodman NY conference.
Get Outlook for Android
From: Brett
Sent: Monday, October 9, 2017 10:08:17 AM
To: Doug Morris
Subject: Re: Phase 2 CML
HI Doug,
My bad, I must have missed that announcement. Can you point me to the press release where BioPath publicly announced that enrollment for phase 2 CML is open?
Thanks,
Brett
On Mon, Oct 9, 2017 at 11:41 AM, Doug Morris <dmorris@biopathholdings.com> wrote:
Brett:
The Company announced that patient enrollment is now open, we have not announced a patient is enrolled. There is a difference of course.
Have a great day.
Get Outlook for Android
From: Brett
Sent: Monday, October 9, 2017 9:29:20 AM
To: Doug Morris
Subject: Re: Phase 2 CML
Doug,
I’m confused, are you saying enrollment is open for the CML study but no patients have yet been recruited? I understand the challenges of patient recruitment, it’s just news to me that the study is enrolling.
Sent from my iPhone
On Oct 9, 2017, at 10:23 AM, Doug Morris <dmorris@biopathholdings.com> wrote:
Hi Brett:
I am aware of the time frame. As you know by know we can only professionally nudge the medical site to enroll patients. It is not in our direct control.
Best,
Doug
From: Brett
Sent: Monday, October 9, 2017 9:05 AM
To: Doug Morris <dmorris@biopathholdings.com>
Subject: Re: Phase 2 CML
Hi Doug,
It’s now been 6 weeks since Harvey and no updates. . .
Sent from my iPhone
On Sep 21, 2017, at 2:27 PM, Doug Morris <dmorris@biopathholdings.com> wrote:
Hi Brett:
Unfortunately Harvey slowed the process down 3 to 4 weeks, but be on the lookout for a release.
Thank you,
Doug
Get Outlook for Android
From: Brett
Sent: Thursday, September 21, 2017 8:07:03 AM
To: Doug Morris
Subject: Phase 2 CML
Doug,
If enrollment for phase two for CML was initiated last week, as Peter indicated in his presentation, why hasn’t there been a press release? This company desperately needs to provide news to the market and the initiation of a study that has been promised for 3 years seems newsworthy to me! Unless of course enrollment hasn’t started, which wouldn’t be a surprise.
